Eric Litvin shares the latest NPR Business News : FDA Approval Could Turn A Free Drug For A Rare Disease Pricey

FDA Approval Could Turn A Free Drug For A Rare Disease Pricey
Jacobus Pharmaceutical freely gives its experimental drug to patients with a rare disease. Now a rival wants FDA approval to sell its own version — and expects to charge at least $37,500 per year.

Read more on NPR